GLOBAL - Global index group FTSE has launched a new index, the FTSE techMARK mediscience, designed to reflect the market performance of growth companies listed on the London Stock Exchange's (LSE) new market, techMARK mediscience.
The new index will begin calculation today. FTSE techMARK mediscience will provide investors in small and mid-sized companies from the healthcare industry with the a measurement tool of the new medical market. The new index forms part of the FTSE techMARK Index Series, and will be reviewed quarterly, by an independent committee of market users.
Commenting on the techMARK mediscience market, Martin Wheatley, deputy CEO of LSE, said “The mediscience industry attracts a lot of interest – from issuers, investors, intermediaries and the media alike.
“By providing focus, techMARK mediscience will draw liquidity to this new market and make investment decisions easier.”
By Janet Du Chenne
Royal London saw its new group pension business decline over the first half of 2018 as the rollout of auto-enrolment (AE) drew to a close, according to its interim results.
Now Pensions has made "huge progress" in resolving legacy administration issues - switching systems and completing unit adjustment for a "large proportion" of members, it says.
Trustees of the Airways Pension Scheme (APS) will not make a firm decision on whether to appeal the Court of Appeal's judgment on discretionary increase payments until September.
Accountant Hashmukh Shah has pleaded guilty to deliberately providing false information to The Pensions Regulator (TPR) when stating a pension scheme had been set up for staff of a London-based restaurant.